Global HIV Self-Diagnostic Test Market Growth (Status and Outlook) 2023-2029

Global HIV Self-Diagnostic Test Market Growth (Status and Outlook) 2023-2029

HIV is detected by HIV-1 and HIV-2 antibodies from the individual’s biological material placed in the HIV self-diagnostic testing apparatus. In HIV self-diagnostic testing, presence antibodies against HIV present in the blood and biological fluids is detected by flow-through technology.

LPI (LP Information)' newest research report, the “HIV Self-Diagnostic Test Industry Forecast” looks at past sales and reviews total world HIV Self-Diagnostic Test sales in 2022, providing a comprehensive analysis by region and market sector of projected HIV Self-Diagnostic Test sales for 2023 through 2029. With HIV Self-Diagnostic Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HIV Self-Diagnostic Test industry.

This Insight Report provides a comprehensive analysis of the global HIV Self-Diagnostic Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HIV Self-Diagnostic Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HIV Self-Diagnostic Test market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HIV Self-Diagnostic Test and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HIV Self-Diagnostic Test.

The global HIV Self-Diagnostic Test market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for HIV Self-Diagnostic Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for HIV Self-Diagnostic Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for HIV Self-Diagnostic Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key HIV Self-Diagnostic Test players cover Autotest VIH, BioLytical Laboratories, BioSure UK, OraSure Technologies, Inc., Atomo Diagnostics, Biosynex, NEXUS Laboratories and Nectar Lifesciences Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of HIV Self-Diagnostic Test market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Finger-Stick Sample (Blood)
Oral Swab
Others

Segmentation by application
Hospital Pharmacies
Retail Pharmacy
Online Pharmacy
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Autotest VIH
BioLytical Laboratories
BioSure UK
OraSure Technologies, Inc.
Atomo Diagnostics
Biosynex
NEXUS Laboratories
Nectar Lifesciences Limited

Please note: The report will take approximately 2 business days to prepare and deliver.